topical gel

traffic light green light

Pharma

DermBiont's topical gel hits goal in benign skin growth phase 2

Twenty months after acquiring the topical drug candidate SM-020, DermBiont has linked the prospect to improved outcomes in people with benign tumors.

Nick Paul Taylor Jun 28, 2022 9:55am

Dermatology

Almirall: 'Listen to what your marks whisper to you'

May 26, 2022 9:55am

FDA Building

In a first, FDA approves topical drug for rare disease lesions

Apr 5, 2022 7:35am